Toshio Sasajima
Akita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Long-term Outcomes of Hypofractionated Stereotactic Radiotherapy for the Treatment of Perioptic Nonfunctioning Pituitary Adenomas.
Journal: Neurologia medico-chirurgica
Published: May 17, 2021
Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group.
Journal: Neurologia medico-chirurgica
Published: October 19, 2020
Intracranial Growing Teratoma Syndrome:Case Reports and Literature Review
Journal: No shinkei geka. Neurological surgery
Published: July 23, 2020
Opening the ventricle during surgery diminishes survival among patients with newly diagnosed glioblastoma treated with carmustine wafers: a multi-center retrospective study.
Journal: Journal of neuro-oncology
Published: December 06, 2016
Rapid immunohistochemistry for brain tumor
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: September 01, 2016
Pathological diagnosis using intraoperative rapid immunohistochemistry
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: September 01, 2016
Long-Term Follow-Up for a Giant Basilar Trunk Aneurysm Surgically Treated by Proximal Occlusion and External Carotid Artery to Posterior Cerebral Artery Bypass Using a Saphenous Vein Graft.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: April 18, 2016
Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma.
Journal: Nuclear medicine and biology
Published: September 30, 2014
Erratum to: Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors.
Journal: Brain tumor pathology
Published: July 02, 2014
Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
Journal: Nuclear medicine and biology
Published: March 08, 2013
Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study.
Journal: Journal of neuro-oncology
Published: January 21, 2013
Last Updated: 09/26/2026